EXANE DERIVATIVES - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$225,000
-93.7%
3
-93.5%
0.00%
-100.0%
Q1 2022$3,593,000
-31.2%
46
-20.7%
0.00%0.0%
Q4 2021$5,223,000
-87.4%
58
-87.1%
0.00%
-90.0%
Q3 2021$41,615,000
+10.2%
450
-17.4%
0.01%
+11.1%
Q2 2021$37,757,000
-7.0%
5450.0%0.01%
-25.0%
Q1 2021$40,617,000
-62.5%
545
-14.3%
0.01%
-62.5%
Q4 2020$108,427,000
+21.4%
6360.0%0.03%
+23.1%
Q3 2020$89,309,000
-12.4%
6360.0%0.03%
-3.7%
Q2 2020$101,969,000
+63.9%
6360.0%0.03%
+58.8%
Q1 2020$62,211,000
-76.4%
636
-68.6%
0.02%
-65.3%
Q4 2019$263,390,000
+72.9%
2,0230.0%0.05%
+81.5%
Q3 2019$152,343,000
-50.4%
2,0230.0%0.03%
-50.0%
Q2 2019$307,277,000
+27.5%
2,0230.0%0.05%
+12.5%
Q1 2019$241,028,000
+27.1%
2,023
+16.4%
0.05%
+41.2%
Q4 2018$189,609,000
-16.1%
1,738
+24.1%
0.03%
-19.0%
Q3 2018$226,029,000
+22.2%
1,4000.0%0.04%
+35.5%
Q2 2018$184,974,0001,4000.03%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Casdin Capital, LLC 1,010,330$122,472,20313.56%
Finepoint Capital LP 145,357$17,620,1768.78%
Avoro Capital Advisors LLC 4,025,000$487,910,5007.61%
Saturn V Capital Management LP 118,401$14,352,5696.01%
Ghost Tree Capital, LLC 150,000$18,183,0005.98%
Ikarian Capital, LLC 3,673$44,524,1065.36%
ACUTA CAPITAL PARTNERS, LLC 550$7,580,6505.08%
Eagle Health Investments LP 174,212$21,117,9794.65%
Boxer Capital, LLC 600,000$72,732,0003.87%
GREAT POINT PARTNERS LLC 165,200$20,025,5443.65%
View complete list of SAREPTA THERAPEUTICS INC shareholders